A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors
Clinical trial NCT02304393 · COMPLETED
Trial details
- NCT number
- NCT02304393
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-12
- Primary completion
- 2019-11-07
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.